Celldex Therapeutics Inc. (CLDX)

2.52
0.06 2.33
NASDAQ : Health Technology
Prev Close 2.58
Open 2.64
Day Low/High 2.49 / 2.68
52 Wk Low/High 2.40 / 11.62
Volume 584.17K
Avg Volume 422.10K
Exchange NASDAQ
Shares Outstanding 13.77M
Market Cap 34.84M
EPS -14.50
P/E Ratio N/A
Div & Yield N.A. (N.A)
Today's Dead Cat Bounce Stock: Celldex Therapeutics (CLDX)

Today's Dead Cat Bounce Stock: Celldex Therapeutics (CLDX)

Trade-Ideas LLC identified Celldex Therapeutics (CLDX) as a "dead cat bounce" (down big yesterday but up big today) candidate

Celldex Therapeutics (CLDX) Showing Signs Of Perilous Reversal Today

Celldex Therapeutics (CLDX) Showing Signs Of Perilous Reversal Today

Trade-Ideas LLC identified Celldex Therapeutics (CLDX) as a "perilous reversal" (up big yesterday but down big today) candidate

Celldex Therapeutics (CLDX) Is Strong On High Volume Today

Celldex Therapeutics (CLDX) Is Strong On High Volume Today

Trade-Ideas LLC identified Celldex Therapeutics (CLDX) as a strong on high relative volume candidate

Watch Out: Barbarians At The Gate For Celldex Therapeutics (CLDX)

Watch Out: Barbarians At The Gate For Celldex Therapeutics (CLDX)

Trade-Ideas LLC identified Celldex Therapeutics (CLDX) as a "barbarian at the gate" (strong stocks crossing above resistance with today's range greater than 200%) candidate

First Week of CLDX December 18th Options Trading

First Week of CLDX December 18th Options Trading

Investors in Celldex Therapeutics, Inc. saw new options become available this week, for the December 18th expiration.

Trade-Ideas: Celldex Therapeutics (CLDX) Is Today's Strong On High Relative Volume Stock

Trade-Ideas: Celldex Therapeutics (CLDX) Is Today's Strong On High Relative Volume Stock

Trade-Ideas LLC identified Celldex Therapeutics (CLDX) as a strong on high relative volume candidate

CLDX January 2018 Options Begin Trading

CLDX January 2018 Options Begin Trading

Investors in Celldex Therapeutics, Inc. saw new options begin trading today, for the January 2018 expiration.

Celldex Therapeutics (CLDX) Strong On High Relative Volume Today

Celldex Therapeutics (CLDX) Strong On High Relative Volume Today

Trade-Ideas LLC identified Celldex Therapeutics (CLDX) as a strong on high relative volume candidate

5 Stocks Ready for Breakouts

5 Stocks Ready for Breakouts

These stocks look ready to break out and trade higher from current levels.

10 Worst NASDAQ Biotech Stocks in the Third Quarter

10 Worst NASDAQ Biotech Stocks in the Third Quarter

The third quarter was brutal for biotech stocks. Here are the companies that fared the worst.

Interesting CLDX Put And Call Options For October 16th

Interesting CLDX Put And Call Options For October 16th

Investors in Celldex Therapeutics, Inc. saw new options begin trading this week, for the October 16th expiration.

Relative Strength Alert For Celldex Therapeutics

Relative Strength Alert For Celldex Therapeutics

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Today's Dead Cat Bounce Stock: Celldex Therapeutics (CLDX)

Today's Dead Cat Bounce Stock: Celldex Therapeutics (CLDX)

Trade-Ideas LLC identified Celldex Therapeutics (CLDX) as a "dead cat bounce" (down big yesterday but up big today) candidate

The Numbers Behind Biotech's Horrible, No Good, Awful August

The Numbers Behind Biotech's Horrible, No Good, Awful August

Among all U.S.-listed biotech stocks, regardless of market cap, only 68 companies managed to end August with higher stock prices, while 267 biotech stocks lost ground.

Insider Trading Alert - SWI, CLDX And CLGX Traded By Insiders

Insider Trading Alert - SWI, CLDX And CLGX Traded By Insiders

Stocks with insider trader activity include SWI, CLDX and CLGX

Perilous Reversal Stock: Celldex Therapeutics (CLDX)

Perilous Reversal Stock: Celldex Therapeutics (CLDX)

Trade-Ideas LLC identified Celldex Therapeutics (CLDX) as a "perilous reversal" (up big yesterday but down big today) candidate

Northwest Bio Forced to Temporarily Halt Enrollment of Brain Tumor Vaccine Study (Update)

Northwest Bio Forced to Temporarily Halt Enrollment of Brain Tumor Vaccine Study (Update)

Enrollment of new patients into the DCVax-L study is suspended until the company "submits certain information from the trial for regulatory review," Northwest Bio said.

Celldex Therapeutics (CLDX) Is Today's Dead Cat Bounce Stock

Celldex Therapeutics (CLDX) Is Today's Dead Cat Bounce Stock

Trade-Ideas LLC identified Celldex Therapeutics (CLDX) as a "dead cat bounce" (down big yesterday but up big today) candidate

Biotech Stock Mailbag: Celldex, Bluebird, Kite, Inovio

Biotech Stock Mailbag: Celldex, Bluebird, Kite, Inovio

Biotech columnist Adam Feuerstein answers readers' questions about health care.

CLDX: Insiders vs. Shorts

CLDX: Insiders vs. Shorts

The most recent short interest data was recently released by the NASDAQ for the 07/31/2015 settlement date, and Celldex Therapeutics, Inc. is one of the most shorted stocks of the Russell 3000, based on 13.32 "days to cover" versus the median component at 5.46.

Market Wrap: Stocks Retreat on China Devaluation

However, utilities and some technology names bucked the trend.

Celldex Reports Second Quarter 2015 Results

Celldex Reports Second Quarter 2015 Results

Conference Call Scheduled for Monday, August 10 at 4:30 p.m. Eastern Time

Celldex To Report Second Quarter 2015 Financial Results And Host Corporate 2015 Objectives Update Call

Celldex To Report Second Quarter 2015 Financial Results And Host Corporate 2015 Objectives Update Call

Conference Call Scheduled for Monday, August 10 at 4:30 p.m. Eastern Time

Weak On High Volume: Celldex Therapeutics (CLDX)

Weak On High Volume: Celldex Therapeutics (CLDX)

Trade-Ideas LLC identified Celldex Therapeutics (CLDX) as a weak on high relative volume candidate

Strong On High Relative Volume: Celldex Therapeutics (CLDX)

Strong On High Relative Volume: Celldex Therapeutics (CLDX)

Trade-Ideas LLC identified Celldex Therapeutics (CLDX) as a strong on high relative volume candidate

TheStreet Quant Rating: D- (Sell)